Literature DB >> 30089309

Gene Co-Expression Network Analysis Implicates microRNA Processing in Parkinson's Disease Pathogenesis.

Jason A Chen.   

Abstract

BACKGROUND: Recent advances in genetics have provided insights into important inherited causes of Parkinson's disease (PD), but the underlying biological mechanisms are still incompletely understood. Gene expression studies have pointed toward the dysregulation of neuroinflammation, mitochondrial function, and protein degradation pathways.
OBJECTIVE: We aimed to identify groups of dysregulated genes in PD.
METHODS: In order to increase statistical power and control for potential confounders, we re-analyzed transcriptomic data from PD patients and model systems, integrating additional genomic data using a systems biology approach. Using weighted gene co-expression network analysis, we partitioned genes into co-expressed modules.
RESULTS: One co-expression module, M13, had an expression trajectory that was highly correlated with PD, was not characterized by any specific cell type markers, and was enriched in PD genes identified by genome-wide association studies. Genes within M13 seemed to be related to global microRNA biogenesis, and DICER1 and AGO3 were highly connected within the module. The NUCKS1 gene, previously identified as part of the PARK16 locus, was also a hub gene within M13.
CONCLUSION: These results suggest that microRNA processing and function may play a role in the pathogenesis of PD, and thus may represent a useful target for future drug development.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Gene expression; Genomics; Micro-RNA; Parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 30089309     DOI: 10.1159/000490427

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  4 in total

1.  Identification and analysis of spinal cord injury subtypes using weighted gene co-expression network analysis.

Authors:  Qi Chen; Ziru Zhao; Guoyong Yin; Chuanjun Yang; Danfeng Wang; Zhi Feng; Na Ta
Journal:  Ann Transl Med       Date:  2021-03

Review 2.  The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson's Disease.

Authors:  Simoneide S Titze-de-Almeida; Cristina Soto-Sánchez; Eduardo Fernandez; James B Koprich; Jonathan M Brotchie; Ricardo Titze-de-Almeida
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

3.  Functional association between NUCKS1 gene and Parkinson disease: A potential susceptibility biomarker.

Authors:  Sarita Singh; Prahlad Kishore Seth
Journal:  Bioinformation       Date:  2019-09-05

Review 4.  Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease.

Authors:  Emilia Pascale; Giuseppina Divisato; Renata Palladino; Margherita Auriemma; Edward Faustine Ngalya; Massimiliano Caiazzo
Journal:  Biomolecules       Date:  2020-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.